3D Printing and Personalized Medicine: Advancing Drug Delivery Systems
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Drug Delivery and Controlled Release".
Deadline for manuscript submissions: 31 July 2026
Special Issue Editors
Interests: cancer; infectious diseases; nanoencapsulation; nanomedicine; nanoparticles; new drug delivery systems; polymersome; theragnosis
Special Issues, Collections and Topics in MDPI journals
Interests: pharmaceutical 3D printing; bioprinting; hot melt extrusion; additive manufacturing; continuous manufacturing; spray drying; twin-screw granulation; amorphous solid dispersions; solubility and bioavailability enhancement of poorly soluble drugs; tailored drug release strategies; solid oral dosage forms; implants; ocular formulations; colon-targeted drug delivery; personalized medicine; smart dosage forms
Special Issue Information
Dear Colleagues,
The intersection of 3D printing and personalized medicine is revolutionizing the field of drug delivery. Additive manufacturing offers unprecedented control over dosage form geometry, composition, and release kinetics, enabling the design of tailored therapies for specific patient populations. As healthcare shifts toward individualized treatments, there is a growing need for on-demand, scalable, and patient-specific pharmaceutical solutions that improve therapeutic outcomes and compliance.
This Special Issue aims to explore recent advances, innovations, and challenges in the development of 3D-printed drug delivery systems that support the goals of personalized medicine. We welcome contributions that address pharmaceutical design, formulation optimization, digital workflows, process engineering, and regulatory considerations related to 3D printing technologies.
By providing a multidisciplinary platform, this Special Issue seeks to bring together scientists, engineers, clinicians, and regulatory experts to showcase how 3D printing is transforming the future of pharmaceutics and healthcare.
We invite original research articles and reviews. Suggested themes and article types include the following:
- Pharmaceutical applications of fused deposition modeling (FDM), inkjet, SLS, and SLA printing.
- Personalized drug dosage and patient-specific geometries.
- Three-dimensional printing of solid, semi-solid, and transdermal dosage forms.
- Drug–excipient compatibility and preformulation strategies.
- Hot-melt extrusion (HME) and 3D printing integration.
- Controlled, pulsatile, or multi-layer drug release systems.
- Computational modeling, AI, and digital design tools for formulation.
- Regulatory frameworks and quality-by-design (QbD) in additive manufacturing.
- Pediatric, geriatric, and rare disease-targeted dosage forms.
- Clinical translation and industrial scalability of 3D-printed pharmaceuticals.
We look forward to your valuable contributions.
Dr. Hyun-Ouk Kim
Dr. Abdullah Alzahrani
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- 3D printing
- personalized medicine
- additive manufacturing
- fused deposition modeling (FDM)
- hot-melt extrusion (HME)
- solid dosage forms
- tailored drug release
- in silico formulation
- quality-by-design (QbD)
- digital pharmaceutics
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
